Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$120,165,474
in 11 filings, $3.7M under 10b5-1 plans

Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-07-20 Murcko Mark Director Conversion · Series A Convertible Preferred Stock −1,000,000 0
2020-07-20 Murcko Mark Director Conversion · Series B Convertible Preferred Stock −990,099 0
2020-07-20 Rubin Jami Director Purchase +25,000 $20.00 $500K 25,000
2020-07-20 INGRAM DOUGLAS S Director Purchase +25,000 $20.00 $500K 25,000
2020-07-20 Adams Brian General Counsel Purchase +10,000 $20.00 $200K 10,000
2020-07-20 Borisy Alexis Director Conversion +104,487 104,487
2020-07-20 Borisy Alexis Director Conversion · Series C Convertible Preferred Stock −371,027 0
2020-07-20 Picularium, LLC 10% owner Conversion +3,281,253 3,281,253
2020-07-20 Picularium, LLC 10% owner Conversion · Series A Preferred Stock, $0.001 par value per share −9,999,999 0
2020-07-20 Picularium, LLC 10% owner Conversion · Series C Preferred Stock, $0.001 par value per share −1,651,471 0
2020-07-20 Alexandria Venture Investments, LLC 10% owner Conversion +968,365 968,365
2020-07-20 Alexandria Venture Investments, LLC 10% owner Conversion · Series A Preferred Stock −500,000 0
2020-07-20 Alexandria Venture Investments, LLC 10% owner Conversion · Series B Preferred Stock −1,287,128 0
2020-07-20 Alexandria Venture Investments, LLC 10% owner Conversion · Series C Preferred Stock −1,651,471 0

Page 27 of 27 · 534 trades